Tags: US | Earns | Eli | Lilly

Drugmaker Eli Lilly Turns Profit as Sales Jump

Thursday, 28 Jan 2010 06:59 AM

Pharmaceutical company Eli Lilly and Co. says it turned a fourth-quarter profit after recording a loss in 2008 following the buyout of cancer drug maker ImClone Systems Inc.

The Indianapolis company earned $915.4 million, or 83 cents per share, in the three months that ended Dec. 31. That compares to a loss of $3.63 billion, or $3.31 per share, in the same period a year earlier. Revenue was up 14 percent to $5.93 billion.

Excluding charges, Lilly earned 91 cents per share.

On that basis, analysts forecast earnings per share of 92 cents for the quarter on $5.67 billion in revenue.

Sales of its top-selling drug, the antipsychotic Zyprexa, climbed 19 percent to $1.37 billion, while the second-best seller, the antidepressant Cymbalta, saw sales rise 15 percent to $830.8 million.

© Copyright 2017 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

 
1Like our page
2Share
Companies
Pharmaceutical company Eli Lilly and Co. says it turned a fourth-quarter profit after recording a loss in 2008 following the buyout of cancer drug maker ImClone Systems Inc.The Indianapolis company earned $915.4 million, or 83 cents per share, in the three months that ended...
US,Earns,Eli,Lilly
130
2010-59-28
Thursday, 28 Jan 2010 06:59 AM
Newsmax Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved